ARTICLE | Company News
Paradigm, Cure Forward deal
August 3, 2015 7:00 AM UTC
The companies partnered to provide oncology patients with personalized molecular information related to their disease. Results from Paradigm’s next-generation sequencing (NGS)-based PCDx test will be ...